Etravirine

依曲韦林

Report date: 2022/05/11 12:43:02
NME

Base Information

Drug NameEtravirine
Drug Alias NameetravirinumetravirinaIntelenceR-165335TMC-125
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReverse transcriptase inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsInflammationInsulin ResistanceFriedreich Ataxia +[4] 
Global Approved IndicationsHIV Infections
Approved Indications in ChinaHIV Infections
Original Approved Country/TerritoryUnited States
Original Approved Date2008/01/18
Country/TerritoryBelgiumCanadaPanama +[31] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTibotec
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson Innovative MedicineJanssen-Cilag International NvTibotec +[7] 
Inactive CompaniesJanssen-Cilag TibotecJanssen-Cilag A.G., SwitzerlandTibotec Pharmaceuticals, Ireland +[6] 
Active IndicationsFriedreich AtaxiaHIV Infections
Inactive IndicationsInflammationInsulin Resistance

Other Information

ATC CodeJ05AG04
Related LinksWikipediaDrugBankKEGG